Details
The document's own metadata, straight from the source system.
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Aug 7, 2026Epiphany DermatologyOpposeBusiness
Summer Hardcastle, a medical receptionist at Epiphany Dermatology, opposes the proposed CY 2027 Medicare Physician Fee Schedule. She argues that the proposed payment reductions for same-day evaluation and management services will hinder patient access to timely dermatologic care and create staffing pressures for community practices.
Read comment → - Aug 6, 2026515 Therapy and ConsultingOpposeBusiness
The owner of a behavioral health practice in Iowa opposes the proposed reduction in Medicare reimbursement for 2027. They argue that lower reimbursement rates will increase financial strain on providers, hinder recruitment of clinicians, and negatively impact access to mental health services.
Read comment → - Aug 6, 2026Epiphany DermatologyOpposeBusiness
Jessica J Solberg, a medical assistant at Epiphany Dermatology, opposes the proposed Medicare Physician Fee Schedule policy that would reduce payments for separately identifiable evaluation and management services performed on the same day as a medically necessary procedure. She argues that the reduction would create barriers to timely care, increase administrative burdens, and negatively impact patient access and outcomes.
Read comment → - Aug 6, 2026The Dermatology Institute and Skin Cancer CenterOpposeBusiness
Dr. Charles Knapp, co-founder of The Dermatology Institute and Skin Cancer Center, opposes the proposed Medicare Physician Fee Schedule due to concerns over declining reimbursement rates. He argues that the proposed payment reductions, combined with rising operational costs, threaten the financial viability of independent practices and may lead to reduced patient access and forced consolidation.
Read comment → - Aug 5, 2026Pediatric Products, LLCSupportBusiness
A Durable Medical Equipment (DME) supplier argues that CMS should reclassify the nebulizer compressor (HCPCS E0570) from a monthly rental to a one-time purchase. The commenter contends that the current rental model creates excessive administrative burdens, negative cash flow for suppliers, and unnecessary claims volume for Medicare.
Read comment → - Aug 4, 2026Lifepoint HealthSupportIndividualRead comment →
- Aug 4, 2026Envision Eye GroupOpposeBusiness
Dr. Laiyin Ma, a solo ophthalmology specialist, opposes the proposed 50% payment reduction for E/M visits billed with modifier 25 on the same day as global procedures. The commenter argues that the proposal double-counts work, creates inefficient patient care by forcing multiple visits, and increases overall Medicare spending.
Read comment → - Aug 4, 2026Bethany MedicalOpposeBusinessRead comment →
- Aug 4, 2026Big 5 CoalitionOpposeTrade association
The Big Five Coalition, representing medical societies from five states, opposes the proposed CY 2027 reduction in the Medicare physician conversion factor. They argue that physician payments have collapsed relative to inflation and call for a positive update based on the Medicare Economic Index and the elimination of site-of-service payment differentials.
Read comment → - Aug 4, 2026The Ohio State University Wexner Medical CenterOpposeAcademic
The Ohio State University Center for Integrative Health supports the creation of a national reimbursement pathway for Shared Medical Appointments (SMAs) but opposes specific proposed restrictions on group size, session duration, and reimbursement valuation. They argue that the current proposal may undermine the financial sustainability and clinical effectiveness of these programs and request greater flexibility in program design and higher reimbursement rates.
Read comment →
